Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

MRI-Compatible IV Infusion Pump Systems Market Outlook (2022 to 2032)

[250 Pages Report] The global MRI-compatible IV infusion pump systems market is expected to enjoy a valuation of US$ 234.8 Million by the end of 2022, and further expand at a CAGR of 9.5% from 2022 and 2032 to reach a valuation of ~US$ 580.3 Million by 2032. The rising need for providing safe and accurate delivery of intravenous fluids and other drugs during and after MRI scans is pushing the demand for MRI-compatible IV infusion pump systems in the market.

Based on product, device systems dominated the global MRI-compatible IV infusion pump systems market in 2021 with a share of about 90.1% 2021, and the trend is likely to continue during the forecast period.

Attribute Key Statistics
MRI-Compatible IV Infusion Pump Systems Market Base Value (2021) US$ 211.6 Million
Estimated Market Size (2022) US$ 234.8 Million
Projected Market Size (2032) US$ 580.3 Million
Value-based CAGR (2022 to 2032) 9.5%
Market Share of Top 5 Countries 56.9%

Internally powered infusion pumps which can be implanted, are surgically inserted under the skin in the abdominal wall. They consist of a small-gauge plastic catheter attached to a titanium-encased pump assembly with a medication reservoir and refilling port.

It is possible to insert the catheter tip subcutaneously, intravenously, intrathecally, epidurally, intraarterially, and intraperitoneally. The most common medications given using implantable infusion pumps are opioids for pain management, cancer chemotherapy medicines, and baclofen for spasticity.

MRI-compatible IV infusion pump systems have become ideal drug delivery solutions to provide a high level of safety, accuracy, reliability, and ease of use during magnetic resonance imaging procedures due to their non-magnetic construction. They help end users meet the clinical needs of today’s patients by allowing continuous delivery of fluids and medication throughout the MRI care cycle.

The rising prevalence of life-threatening diseases, increasing demand for MRI diagnostics, and surge in the hospitalization of patients are expected to fuel the growth of the MRI-compatible IV infusion pump systems market during the forecast period.

Similarly, an increase in the number of surgical procedures and advancements in MRI-compatible IV infusion pump systems will further boost market growth during the forecast period.

The market value for MRI-compatible IV infusion pump systems was approximately 2.2% of the ~US$ 9.6 Billion global infusion pump market in 2021.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of MRI-Compatible IV Infusion Pump Systems Market from 2012 to 2021 Vs Demand Outlook for 2022 to 2032

The global sales of MRI-compatible IV infusion pump systems are anticipated to rise at 9.5% CAGR between 2022 and 2032, in comparison to the 11.6% CAGR registered from 2012 to 2021.

The rising prevalence of chronic and infectious diseases worldwide, the surge in minimally invasive procedures, the growing need for safe and continuous drug delivery during and after MRI scans, and advancement in medical technology are some of the key factors expected to drive growth in the global MRI-compatible IV infusion pump systems market.

In biomedical imaging labs, syringe pumps are frequently employed to provide contrast chemicals and inject or infuse a specific volume of liquids. Each year, improper medicinal delivery leads to millions of unfavorable side effects globally.

MRI IV infusion systems enable a continuous supply of fluids and drugs throughout the MRI treatment cycle, meeting the demanding clinical needs of today's patients. The non-magnetic designs of many systems enable the infusion pump to function safely in extremely strong magnetic fields without resorting to the workarounds typical of conventional infusion pumps.

It can take several days to diagnose a critically ill patient with an MRI after waiting for them to be stable enough to stop receiving all continuous IV infusions. This MRI diagnosis hold-up not only increases costs significantly but also delays a patient's diagnosis, associated care, and discharge.

Critical patient transportation for MRIs is proven to have a favorable risk/benefit ratio. In the vast majority of situations involving critically ill patients, the results from diagnostic evaluations have directly resulted in a shift in patient therapy and management. The patient's time away from their care unit is shortened by connecting them to an MRI infusion pump in the department from which they originated, such as an intensive care unit.

Thus, with a high prevalence of chronic diseases, lifestyle changes, improper diet, and age-related ailments; there is a large growth in the volume of in-patient admissions globally. Enhancing positive patient outcomes in any healthcare setting is at a forefront of comprehensive care, and keeping the above-mentioned points in consideration, the market for MRI-compatible IV infusion pump systems is expected to witness an impressive growth rate during the forecast period.

MRI-Compatible IV Infusion Pump Systems Market

What are the Key Trends Driving the MRI-Compatible IV Infusion Pump Systems Market?

Growing Usage of MRI-Compatible IV Infusion Pump Systems Over Conventional Ones Bolstering Growth”

With rising awareness about the potential benefits of MRI-compatible IV infusion pump systems, end users are rapidly shifting their preference from conventional infusion pumps towards these drug delivery systems. This is expected to bolster market growth during the forecast period.

Device engineering and updates include several clinical and device-based limitations, which need to be addressed for overall patient safety and device incorporation. One such factor includes the prevalence of infusion-based medication errors.

The prevention of drug errors is greatly aided by advanced infusion pumps. They include a large, high-contrast color touch screen, which provides the clinical staff of a hospital with several essential technical resource capabilities in terms of patient safety. The drug is given to the patient at any one time and its concentration, the amount given, and the rate of infusion are all displayed on the screen.

Drug libraries, which set limits on the medication delivered, are also integrated with these infusion pumps. Innovative solutions encourage both objective and subjective patient safety, thereby enhancing the total quality of healthcare.

Keeping the above factors in consideration, the market for MRI-compatible IV infusion pump systems market is expected to register lucrative growth over the projected years.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining Growth in MRI-Compatible IV Infusion Pump Systems Market?

Largely, infusion pump malfunctioning has been reported to be a leading cause of MRI-related deaths, followed by burns, projectiles, and pacemaker failures. Such occurrences were widely reported in the USA alone, and the FDA (Food and Drug Administration) responded to this problem in 2017 by issuing a specific safety communication.

On IV infusion pumps, with the use of contrast agents, the magnetic field can have life-threatening effects such as increased drug delivery rates, including the discharge of the entire pump's contents in a single lethal dose.

These effects also result in decreased drug delivery rates, and permanent device failure because the pump magnet has become demagnetized. Gadolinium, a rare earth metal included in MRI contrast agents, interacts with the magnetic field produced by MRI equipment.

MRI images created using gadolinium-based contrast agents (GBCAs) are as precise as they can be. However, they do have some risks and are not necessary for all MRIs. Similarly, MRI-compatible IV infusion pump systems are more expensive than conventional ones.

All these limitations of these devices are expected to negatively influence the global MRI-compatible IV infusion pump systems market over the forecast years.

Country-wise Insights

What Makes the USA a Dominant MRI-Compatible IV Infusion Pump Systems Market?

“Continuous New Product Launches and Approvals Driving Market in the USA”

The USA dominates the North American MRI-compatible IV infusion pump systems market with a total market share of about 70.1% in 2021 and it is further expected to expand at a prolific CAGR of 13.6% during the forecast period. Growth in the U.S. MRI-compatible IV pump systems market is driven by increasing incidence of chronic disease, availability of advanced FDA-approved medical devices, rise in the number of hospital admissions, and presence of favorable reimbursement policies.

The country has a stronghold of several established manufacturers within the MRI-compatible IV infusion pump systems market space. These manufacturers are continuously focusing on launching new products and getting approvals from regulatory bodies.

For instance, in 2017 Iradimed Corp. announced that its MRidium 3860+ IV infusion pump system, which incorporates its Dose Error Reduction System (DERS) software function, received the US FDA 510(k) clearance.

How Will Growth Unfold in Germany’s MRI-Compatible IV Infusion Pump Systems Market?

“Flourishing Medical Tourism Augmenting Sales of MRI-Compatible IV Infusion Pump System Sales in Germany”

Germany held a market share of about 7.0% in the global MRI-compatible IV infusion pump systems market in 2021 and it is likely to grow at a robust CAGR during the next ten years. Rising medical tourism, increasing Research and Development efforts, a fast-growing insurance industry, and a rise in demand for smart infusion pumps are some of the factors driving the market's expansion within the nation.

Similarly, the surge in various chronic and infectious diseases across the country and increasing hospitalizations are expected to propel the demand for advanced drug delivery systems like MRI-compatible IV infusion systems during the forecast period.

What Makes China a Highly Lucrative MRI-Compatible IV Infusion Pump Systems Market?

“Rapid Expansion of Healthcare Sector Propelling Demand in China”

China held approximately 6.4% share of the global market in 2021 and it is expected to remain one of the most lucrative markets for MRI-compatible IV infusion pumps systems across East Asia during the forecast period.

Growth in China’s MRI-compatible IV infusion pump systems market is driven by the rapidly growing geriatric population, the surge in chronic disease burden, a rise in the number of patients undergoing treatments at hospitals, and the robust expansion of the healthcare industry.

Besides this, the easy availability of various drug delivery systems at much lower prices will further expand the MRI-compatible IV infusion pump systems market size over the next ten years.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which is the Most Used Product in MRI-Compatible IV Infusion Pump Systems Market?

“Demand to Remain High for MRI-Compatible IV Infusion Pump Devices in the Market”

As per FMI, the device system segment held the highest share of around 90.1% in the global MRI-compatible IV infusion pump systems market in 2021 and it is likely to retain its dominance during the forthcoming period. This can be attributed to the rising usage of MRI-compatible IV infusion pump device systems across healthcare facilities.

Many device systems have introduced the concept of portability, which has expanded the approach of MRI diagnosis in critically ill patients and reduced the time and length of hospital stay for the patients. This has significantly affected the reduction in costs for hospitalization, and unwanted expenditures by the institutional settings.

Which is the Leading End User in MRI-Compatible IV Infusion Pump Systems?

“Hospitals to be the Leading End User for MRI Compatible IV Infusion Pump Systems Market”

The hospital's segment held a revenue share of about 63.7% of the global MRI-compatible IV infusion pump systems market in 2021 and this number is expected to reach around 74.4% by 2032. This can be attributed to the increasing hospitalizations, rise in the volume of surgical procedures performed in hospitals, availability of trained staff, and a vigilant treatment flow.

Competitive Landscape

Leading players in MRI-compatible IV infusion pump systems market are adopting strategies such as new product launches and approvals, device patenting and licensing, as well as regulatory approvals for marketing.

Key instances of development within the market include:

  • In July 2020, IRADIMED CORPORATION reported that the US Patent and Trademark Office had issued a patent that added to earlier assertions regarding the wireless remote control of IV infusion pumps.
  • In April 2020, B. Braun Medical Inc. announced that the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for B. Braun’s Perfusor Space Syringe Infusion Pump, Infusomat space Volumetric Infusion Pump, and Outlook ES Pump systems to treat patients of all ages with or suspected of having COVID-19 and to lessen the exposure of healthcare professionals to such patients during the COVID-19 pandemic
  • In 2016, IRADIMED received FDA clearance for its MRidium 3860+ magnetic resonance imaging (MRI) compatible IV infusion pump system.

Report Scope as per MRI-Compatible IV Infusion Pump Systems Industry Analysis

Attribute Details
Estimated Market Size (2022) US$ 234.8 Million
Projected Market Size (2032) US$ 580.3 Million
Anticipated Growth Rate (2022 to 2032) 9.5%
Forecast Period 2012 to 2021
Historical Data Available for 2022 to 2032
Market Analysis US$ Million for Value
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA)
Key Countries Covered The USA, Canada, Brazil, Mexico, Argentina, The UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa
Key Market Segments Covered Product, End User, and Region
Key Companies Profiled
  • iRadimed Corporation
  • B.Braun Melsungen AG
  • Fresenius Kabi AG
  • Smiths Medical (Smiths Group plc.)
  • Arcomed AG
  • Becton, Dickinson Company (Carefusion)
  • Baxter International Inc.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Key Market Segments Covered in MRI-Compatible IV Infusion Pump Systems Industry Research

By Product:

  • Device System
    • Non-magnetic pump systems
    • Magnetic pump system with shielding
  • Tubing and Disposables

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostics Imaging Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How big is the global MRI-compatible IV infusion pump systems market?

The global MRI-compatible IV infusion pump systems market size reached US$ 211.6 Million in 2021 and is likely to touch a valuation of US$ 234.8 Million by 2032.

What is the sales forecast for the MRI-compatible IV infusion pump systems market through 2032?

Sales of MRI-compatible IV infusion pump systems are set to witness a CAGR of 9.5% during the forecast period (2022 to 2032).

What is the projected valuation for MRI-compatible IV infusion pump systems market in 2032?

The global MRI-compatible IV infusion pump systems market is expected to reach a valuation of US$ 580.3 Million by 2032.

At what rate did the MRI-compatible IV infusion pump systems market grow between 2012 and 2021?

Demand for MRI-compatible IV infusion pump systems market increased at 11.6% CAGR from 2012 to 2021.

Which countries drive the highest demand for MRI-compatible IV infusion pump systems?

The USA, Canada, China, Germany, and Japan are leading countries driving demand for MRI-compatible IV infusion pump systems, collectively holding around 56.9% market share.

What is the USA MRI-compatible IV infusion pump systems market outlook?

The U.S. accounts for around 70.1% share of the North American MRI-compatible IV infusion pump systems market in 2021.

Who are the top three manufacturers of the MRI-compatible IV infusion pump systems market?

iRadimed Corporation, B. Braun Melsungen AG, and Fresenius Kabi AG are the top three manufacturers of MRI-compatible IV infusion pump systems.

How is the MRI-compatible IV infusion pump systems market shaping up in China?

China held a share of about 6.4% in the global MRI-compatible IV infusion pump systems market in 2021.

How big is the MRI-compatible IV infusion pump systems market in Japan?

Japan held a share of about 5.6% within the global MRI-compatible IV infusion pump systems market in 2021.

What is the expected growth outlook of the MRI-compatible IV infusion pump systems market in Germany?

The German MRI-compatible IV infusion pump systems market holds a share value of around 7.0% within the global MRI-compatible IV infusion pump systems market.

Who are the key players within the MRI-compatible IV infusion pump systems market sphere?

The key players within the MRI-compatible IV infusion pump systems market space include iRadimed Corporation, B.Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical (Smiths Group plc.), Arcomed AG, Becton, Dickinson Company (Carefusion), and Baxter International Inc.

Table of Content

1. Executive Summary | MRI-Compatible IV Infusion Pump Systems Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Promotional Strategies, By Key Manufacturers

    4.2. Key Regulations

    4.3. Value Chain Analysis

    4.4. Regulatory Impositions

    4.5. Reimbursement Scenario

    4.6. PESTEL Analysis

    4.7. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Infusion Pumps Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Growing Geriatric Age Group Population

        5.2.2. New Product Launch Activities

        5.2.3. High Prevalence of Chronic Diseases

        5.2.4. Cost of

        5.2.5. Rising Volumes of Surgical Procedures

        5.2.6. Technological Innovations

        5.2.7. Advancement in Minimally Invasive Techniques

        5.2.8. Device Regulations

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By End User

        6.1.3. By Country

    6.2. 2021 Market Scenario

7. Global Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Product

    7.2. Pricing Break-up

        7.2.1. Manufacturer-Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

    7.4. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032

    8.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021

    8.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Market Volume (Units) Analysis 2012 to 2021 and Forecast, 2022 to 2032

    9.1. Historical Market Volume (Units) Analysis, 2012 to 2021

    9.2. Current and Future Market Volume (Units) Projections, 2022 to 2032

        9.2.1. Y-o-Y Growth Trend Analysis

10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2012 to 2021

    10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2032

        10.3.1. Device System

            10.3.1.1. Non-magnetic pump systems

            10.3.1.2. Magnetic pump system with shielding

        10.3.2. Tubing and disposables

    10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2021

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032

        11.3.1. Hospitals

        11.3.2. Ambulatory Surgical Centers

        11.3.3. Diagnostics Imaging Centers

    11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2021

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East & Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021

    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022 to 2032

        13.3.1. By Country

            13.3.1.1. The USA

            13.3.1.2. Canada

        13.3.2. By Product

        13.3.3. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By End User

    13.5. Market Trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

    13.8. Country-Level Analysis & Forecast

        13.8.1. The USA Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast By Market Taxonomy

                13.8.1.2.1. By Country

                13.8.1.2.2. By Product

                13.8.1.2.3. By End User

        13.8.2. Canada Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast By Market Taxonomy

                13.8.2.2.1. By Country

                13.8.2.2.2. By Product

                13.8.2.2.3. By End User

14. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022 to 2032

        14.3.1.  By Country

            14.3.1.1. Mexico

            14.3.1.2. Brazil

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

                14.3.1.4.1. By Country

                14.3.1.4.2. By Product

                14.3.1.4.3. By End User

    14.4. Market Attractiveness Analysis

                14.4.1.1.1. By Country

                14.4.1.1.2. By Product

                14.4.1.1.3. By End User

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country-Level Analysis & Forecast

        14.8.1. Mexico Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast By Market Taxonomy

                14.8.1.2.1. By Product

                14.8.1.2.2. By End User

        14.8.2. Brazil Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast By Market Taxonomy

                14.8.2.2.1. By Country

                14.8.2.2.2. By Product

                14.8.2.2.3. By End User

        14.8.3. Argentina Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast By Market Taxonomy

                14.8.3.2.1. By Product

                14.8.3.2.2. By End User

15. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022 to 2032

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. The UK

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Product

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By End User

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country-Level Analysis & Forecast

        15.8.1. Germany Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast By Market Taxonomy

                15.8.1.2.1. By Product

                15.8.1.2.2. By End User

        15.8.2. Italy Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast By Market Taxonomy

                15.8.2.2.1. By Product

                15.8.2.2.2. By End User

        15.8.3. France Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast By Market Taxonomy

                15.8.3.2.1. By Product

                15.8.3.2.2. By End User

        15.8.4. The UK Market Analysis

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast By Market Taxonomy

                15.8.4.2.1. By Product

                15.8.4.2.2. By End User

        15.8.5. Spain Market Analysis

            15.8.5.1. Introduction

            15.8.5.2. Market Analysis and Forecast By Market Taxonomy

                15.8.5.2.1. By Product

                15.8.5.2.2. By End User

        15.8.6. BENELUX Market Analysis

            15.8.6.1. Introduction

            15.8.6.2. Market Analysis and Forecast By Market Taxonomy

                15.8.6.2.1. By Product

                15.8.6.2.2. By End User

        15.8.7. Russia Market Analysis

            15.8.7.1. Introduction

            15.8.7.2. Market Analysis and Forecast By Market Taxonomy

                15.8.7.2.1. By Product

                15.8.7.2.2. By End User

16. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022 to 2032

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product

        16.3.3. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country-Level Analysis & Forecast

        16.8.1. China Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast By Market Taxonomy

                16.8.1.2.1. By Product

                16.8.1.2.2. By End User

        16.8.2. Japan Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast By Market Taxonomy

                16.8.2.2.1. By Product

                16.8.2.2.2. By End User

        16.8.3. South Korea Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast By Market Taxonomy

                16.8.3.2.1. By Product

                16.8.3.2.2. By End User

17. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022 to 2032

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Indonesia

            17.3.1.3. Malaysia

            17.3.1.4. Thailand

            17.3.1.5. Rest of South Asia

        17.3.2. By Product

        17.3.3. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By End User

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country-Level Analysis & Forecast

        17.8.1. India Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast By Market Taxonomy

                17.8.1.2.1. By Product

                17.8.1.2.2. By End User

        17.8.2. Indonesia Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast By Market Taxonomy

                17.8.2.2.1. By Product

                17.8.2.2.2. By End User

        17.8.3. Malaysia Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast By Market Taxonomy

                17.8.3.2.1. By Product

                17.8.3.2.2. By End User

        17.8.4. Thailand Market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast By Market Taxonomy

                17.8.4.2.1. By Product

                17.8.4.2.2. By End User

18. Oceania Market 2012 to 2021 and Forecast 2022 to 2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022 to 2032

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product

        18.3.3. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By End User

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

    18.7. Country-Level Analysis & Forecast

        18.7.1. Australia Market Analysis

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast By Market Taxonomy

                18.7.1.2.1. By Product

                18.7.1.2.2. By End User

        18.7.2. New Zealand Market Analysis

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast By Market Taxonomy

                18.7.2.2.1. By Product

                18.7.2.2.2. By End User

19. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2022 to 2032

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Turkey

            19.3.1.3. South Africa

            19.3.1.4. North Africa

            19.3.1.5. Rest of Middle East and Africa

        19.3.2. By Product

        19.3.3. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By End User

    19.5. Market Trends

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country-Level Analysis & Forecast

        19.8.1. GCC Countries Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast By Market Taxonomy

                19.8.1.2.1. By Product

                19.8.1.2.2. By End User

        19.8.2. Turkey Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast By Market Taxonomy

                19.8.2.2.1. By Product

                19.8.2.2.2. By End User

        19.8.3. South Africa Market Analysis

            19.8.3.1. Introduction

            19.8.3.2. Market Analysis and Forecast By Market Taxonomy

                19.8.3.2.1. By Product

                19.8.3.2.2. By End User

        19.8.4. North Africa Market Analysis

            19.8.4.1. Introduction

            19.8.4.2. Market Analysis and Forecast By Market Taxonomy

                19.8.4.2.1. By Product

                19.8.4.2.2. By End User

20. Market Structure Analysis

    20.1. Market Analysis By Tier of Companies

    20.2. Market Concentration

    20.3. Market Share Analysis (%) of Top Players

    20.4. Market Presence Analysis

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. iRadimed CorporationOverview

            21.3.1.1. Product Portfolio

            21.3.1.2. Sales Footprint

            21.3.1.3. Key Financials

            21.3.1.4. SWOT Analysis

            21.3.1.5. Strategic Overview

        21.3.2. B.Braun Melsungen AG

            21.3.2.1. Product Portfolio

            21.3.2.2. Sales Footprint

            21.3.2.3. Key Financials

            21.3.2.4. SWOT Analysis

            21.3.2.5. Strategic Overview

        21.3.3. Fresenius Kabi AG

            21.3.3.1. Product Portfolio

            21.3.3.2. Sales Footprint

            21.3.3.3. Key Financials

            21.3.3.4. SWOT Analysis

            21.3.3.5. Strategic Overview

        21.3.4. Smiths Medical (Smiths Group plc.)

            21.3.4.1. Product Portfolio

            21.3.4.2. Sales Footprint

            21.3.4.3. Key Financials

            21.3.4.4. SWOT Analysis

            21.3.4.5. Strategic Overview

        21.3.5. Arcomed AG

            21.3.5.1. Product Portfolio

            21.3.5.2. Sales Footprint

            21.3.5.3. Key Financials

            21.3.5.4. SWOT Analysis

            21.3.5.5. Strategic Overview

        21.3.6. Becton, Dickinson Company (Carefusion)

            21.3.6.1. Product Portfolio

            21.3.6.2. Sales Footprint

            21.3.6.3. Key Financials

            21.3.6.4. SWOT Analysis

            21.3.6.5. Strategic Overview

        21.3.7. Baxter International Inc.

            21.3.7.1. Product Portfolio

            21.3.7.2. Sales Footprint

            21.3.7.3. Key Financials

            21.3.7.4. SWOT Analysis

            21.3.7.5. Strategic Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Recommendations

Healthcare

Central Venous Catheter Market

Published : September 2023

Healthcare

Contrast Media Injectors Market

Published : January 2023

Healthcare

MRI Compatible Patient Monitoring Systems Market

Published : October 2022

Explore Healthcare Insights

View Reports

MRI-Compatible IV Infusion Pump Systems Market